Download

Full Text

See more details

News (6)

X (7)

Clinical guidelines (1)

Mendeley (16)

27

CITATIONS

27 Total citations

16 Recent citations

6.53 Field Citation Ratio

1.74 Relative Citation Ratio

publications

0

supporting

0

mentioning

0

contrasting

0

Smart Citations

0

0

0

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

• Vyas DA, Eisenstein LG, Jones DS (2020) Hidden in plain sight — reconsidering the use of race correction in clinical algorithms. N Engl J Med 383:874–882 DOI: 10.1056/NEJMms2004740
• Kolata G (2020) Many medical decision tools disadvantage black patients. New York Times. New York Times, https://www.nytimes.com/2020/06/17/health/many-medical-decision-tools-disadvantage-black-patients.html. Accessed 28 Aug 2020
• Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244 DOI: 10.1359/jbmr.2002.17.7.1237
• Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256 DOI: 10.1007/s00198-012-1964-3
• Ström O, Lauppe R, Ljunggren Ö, Spångéus A, Ortsäter G, O’Kelly J, Åkesson K (2020) Real-world effectiveness of osteoporosis treatment in the oldest old. Osteoporos Int 31:1525–1533 DOI: 10.1007/s00198-020-05380-6
• Kanis JA, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. Available at http://www.shef.ac.uk/FRAX/index.htm. Accessed 14 Aug 2020
• Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX® with and without BMD. Calcif Tissue Int 90:1–13 DOI: 10.1007/s00223-011-9544-7
• Bonham VL, Sellers SL, Gallagher TH, Frank D, Odunlami AO, Price EG, Cooper LA (2009) Physicians’ attitudes toward race, genetics, and clinical medicine. Genet Med 11:279–286 DOI: 10.1097/GIM.0b013e318195aaf4
• Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp J, Nethander M, Evans D, Morris JA, Kiel DP, Rivadeneira F, Johannson H, Harvey N, Mellström D, Karlsson M, Cooper C, Evans DM, Clark R, Kanis JA, Orwoll E, McCloskey EV, Ohlsson C, Pineau J, Leslie WD, Greenwood CMT, Richards JB (2020) Development of a polygenic risk score to improve screening for fracture risk: a genetic risk prediction study. PLoS Med 17:e1003152. 10.1371/journal.pmed.1003152 DOI: 10.1371/journal.pmed.1003152
• Popham RE, Schmidt W (1981) Words and deeds: the validity of self-report data on alcohol consumption. J Stud Alcohol 42:355–368 DOI: 10.15288/jsa.1981.42.355
• Watson CG, Tilleskjor C, Hoodecheck-Schow EA, Pucel J, Jacobs L (1984) Do alcoholics give valid self-reports? J Stud Alcohol 45:344–348 DOI: 10.15288/jsa.1984.45.344
• Cauley JA, El-Hajj Fuleihan G, Arabi A, Fujiwara S, Ragi-Eis S, Calderon A, Chionh SB, Chen Z, Curtis JR, Danielson ME, Hanley DA, Kroger H, Kung AW, Lesnyak O, Nieves J, Pluskiewicz W, El Rassi R, Silverman S, Schott AM, Rizzoli R, Luckey M, FRAX Position Conference Members (2011) Official positions for FRAX clinical regarding international differences. J Clin Densitom 14:240–262 DOI: 10.1016/j.jocd.2011.05.015
• Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-Y (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fracture. Osteoporos Int 31:1–12 DOI: 10.1007/s00198-019-05176-3
• Kanis JA, Harvey NC, Cyrus Cooper C, Johansson H, Odén A, McCloskey EV, the Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX. A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25. 10.1007/s11657-016-0278-z DOI: 10.1007/s11657-016-0278-z
• Kanis JA, Chandran M, Chionh SB, Ganeson G, Harvey NC, Koh WP, Kwok T, Lau TC, Liu E, Lorentzon M, McCloskey EV, Tan KB, Vandenput L, Johansson H (2020b) Use of age-dependent FRAX-based intervention thresholds for Singapore. Arch Osteoporos 15(1):104. 10.1007/s11657-020-00782-9 DOI: 10.1007/s11657-020-00782-9
• Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381 (Erratum Osteoporos Int 2015; 26: 2045-7) DOI: 10.1007/s00198-014-2794-2
• Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864–1873 DOI: 10.1503/cmaj.100771
• Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, Safford M, Howard G (2009) Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med 24:956–962 DOI: 10.1007/s11606-009-1031-8
• Guggina P, Flahive J, Hooven FH, Watts NB, Siris ES, Silverman S, Roux C, Pfeilschifter J, Greenspan SL, Díez-Pérez A, Cooper C, Compston JE, Chapurlat R, Boonen S, Adachi JD, Anderson FA Jr, Gehlbach S, GLOW Investigators (2012) Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone 51:975–980 DOI: 10.1016/j.bone.2012.08.130
• Sattari M, Cauley JA, Garvan C, Johnson KC, LaMonte MJ, Li W, Limacher M, Manini T, Sarto GE, Sullivan SD, Wactawski-Wende J, Beyth RJ (2017) Osteoporosis in the Women’s Health Initiative: another treatment gap? Am J Med 130:937–948 DOI: 10.1016/j.amjmed.2017.02.042
• Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. 10.1007/s11657-013-0136-1 DOI: 10.1007/s11657-013-0136-1
• Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C, McCloskey EV, Harvey NC, Javaid K, Kanis JA, for the International Osteoporosis Foundation (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15(1):59. 10.1007/s11657-020-0706-y DOI: 10.1007/s11657-020-0706-y
• Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A:1063–1070 DOI: 10.2106/00004623-200008000-00001
• Swedish National Board of Health and Welfare (2009) Quality and efficiency in Swedish Health Care. Swedish Association of Local Authorities and Regions, Swedish National Board of Health and Welfare, Stockholm.
• Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305 DOI: 10.1016/j.semarthrit.2005.11.001
• Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937 DOI: 10.1002/jbmr.2202
• Harvey NCW, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster J-Y, Rizzoli R, Cooper C, Kanis JA (2017) Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 28:1507–1529 DOI: 10.1007/s00198-016-3894-y
• Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E (2017) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res 32:424–430 DOI: 10.1002/jbmr.3074
• Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kužma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35:36–52 DOI: 10.1002/jbmr.3877
• Austin P, Tu J, Ko D, Alter D (2008) Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. CMAJ 179:901–908 DOI: 10.1503/cmaj.080295
• Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928 DOI: 10.1002/jbmr.2301
• Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Compston J, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey MM, Oden A, Papapoulos SE, Poiana C, Wahl DA, McCloskey E, and the Task Force of the FRAX Initiative (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:395–411
• Kanis JA, Harvey NC, Johansson H, Liu E, Lorentzon M, Leslie WD, Eugene V, McCloskey E (2020) A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res 32:187–196 DOI: 10.1007/s40520-019-01432-y